Neovasc Regains Compliance with Nasdaq Minimum Market Value Rule
February 24, 2021 16:05 ET
|
Neovasc, Inc.
VANCOUVER and MINNEAPOLIS, Feb. 24, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN), has received written notification (the "Nasdaq...
Neovasc to Participate in 10th Annual SVB Leerink Global Healthcare Conference
February 17, 2021 09:00 ET
|
Neovasc, Inc.
VANCOUVER, Feb. 17, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neovasc Inc. (NASDAQ, TSX: NVCN), today announced that company management will be participating in the 10th Annual SVB Leerink Global...
Neovasc Announces Closing of US$72 Million Registered Direct Offering of Common Shares Priced At-The-Market
February 12, 2021 15:34 ET
|
Neovasc, Inc.
VANCOUVER, CANADA, Feb. 12, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Neovasc Inc. (“Neovasc” or the “Company”) (Nasdaq: NVCN / TSX: NVCN) announced today that it has closed its previously...
Neovasc Announces US$72 Million Registered Direct Offering Priced At-The-Market
February 10, 2021 07:31 ET
|
Neovasc, Inc.
Vancouver, Canada, Feb. 10, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neovasc Inc. (“Neovasc” or the “Company”) (Nasdaq: NVCN / TSX: NVCN) announced today that it has entered into definitive...
Neovasc Regains Compliance with Nasdaq Minimum Bid Price Rule
February 09, 2021 09:00 ET
|
Neovasc, Inc.
VANCOUVER and MINNEAPOLIS, Feb. 09, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neovasc, Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN) announced today that it has received written...
Neovasc Comments on Journal of the American Heart Association Publication
February 05, 2021 09:00 ET
|
Neovasc, Inc.
VANCOUVER and MINNEAPOLIS, Feb. 05, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neovasc, Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN) today announced that the Journal of the American Heart...
Neovasc Announces 2021 Renewal of German Reimbursement NUB Status 1 Designation for Neovasc Reducer for Treatment of Refractory Angina
February 02, 2021 09:31 ET
|
Neovasc, Inc.
VANCOUVER and MINNEAPOLIS, MN, Feb. 02, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neovasc, Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN) today announced that the German Institute for the...
American Medical Association Issues New CPT Code for Neovasc Reducer Procedure
January 29, 2021 08:00 ET
|
Neovasc, Inc.
VANCOUVER and MINNEAPOLIS, Jan. 29, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neovasc, Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN) announced today that the American Medical Association...
Neovasc Reducer Featured in Three Peer Reviewed Publications Supporting Reducer Therapy
January 19, 2021 08:30 ET
|
Neovasc, Inc.
VANCOUVER and MINNEAPOLIS, MN, Jan. 19, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neovasc Inc. (“Neovasc” or the “Company”) (Nasdaq, TSX: NVCN) announced today the Neovasc Reducer™ (“Reducer”)...
Neovasc Responds to FDA Not-Approvable Letter Regarding Neovasc Reducer™
January 15, 2021 16:59 ET
|
Neovasc, Inc.
VANCOUVER and MINNEAPOLIS, Jan. 15, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neovasc Inc. (“Neovasc” or the “Company”) (Nasdaq, TSX: NVCN) announced today that it has received a “not-approvable”...